etanidazole has been researched along with Hepatocellular Carcinoma in 1 studies
Etanidazole: A nitroimidazole that sensitizes hypoxic tumor cells that are normally resistant to radiation therapy.
etanidazole : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitro-1H-imidazol-1-yl)acetic acid with the amino group of ethanolamine. Used as a radiosensitising agent for hypoxic tumour cells.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ziemer, LS | 1 |
| Evans, SM | 1 |
| Kachur, AV | 1 |
| Shuman, AL | 1 |
| Cardi, CA | 1 |
| Jenkins, WT | 1 |
| Karp, JS | 1 |
| Alavi, A | 1 |
| Dolbier, WR | 1 |
| Koch, CJ | 1 |
1 other study available for etanidazole and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Noninvasive imaging of tumor hypoxia in rats using the 2-nitroimidazole 18F-EF5.
Topics: Animals; Carcinoma, Hepatocellular; Cell Hypoxia; Etanidazole; Feasibility Studies; Fluorine Radiois | 2003 |